NYSE · CIK 0001099800
EW Edwards Lifesciences Corp
Insider trading from SEC Form 4. Last filing Mar 13, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Signals
Open-market buys and sells at Edwards Lifesciences Corp, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 5Weak | sell10b5-1 | BOBO DONALD E JR CVP,Strategy/Corp Development | $646k | 9,500 | -17% | - | |
| 3Weak | sell10b5-1 | BOBO DONALD E JR CVP,Strategy/Corp Development | $492k | 6,500 | -12% | - | |
| 0Weak | sell10b5-1 | BOBO DONALD E JR CVP,Strategy/Corp Development | $344k | 5,000 | -10% | - | |
| 7Weak | sell 510b5-1 | Lippis Daniel J. CVP, JAPAC | $185k | 2,500 | -10% | - | |
| 10Weak | sell 510b5-1 | BOBO DONALD E JR CVP,Strategy/Corp Development | $359k | 5,000 | -10% | - | |
| 34Weak | sell 510b5-1 | Ullem Scott B. CVP, Chief Financial Officer | $806k | 11,250 | -27% | - | |
| 41Moderate | sell 5 | Chopra Daveen CVP, TMTT | $128k | 1,750 | -6% | - | |
| 36Weak | sell 5 | Markowitz Wayne GM & SVP, Surgical | $43k | 583 | -6% | - | |
| 3Weak | sell 210b5-1 | BOBO DONALD E JR CVP,Strategy/Corp Development | $328k | 5,000 | -10% | - | |
| 38Weak | sell 210b5-1 | Wood Larry L Global President TAVR & Surg | $1.6M | 25,000 | -11% | - | |
| 0Weak | sell10b5-1 | BOBO DONALD E JR CVP,Strategy/Corp Development | $348k | 5,000 | -10% | - |
Congressional trades
7 trades in EW disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Alan Armstrong Senate · R-OK | Purchase | EW Edwards Lifesciences Corporation Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Josh Gottheimer House · D-NJ | Sale | EW Edwards Lifesciences Corporation Common Stock | $1,001 to $15k | Nov 19, 2025 | 40 days after the trade |
| Jefferson Shreve House · R-IN | Sale | EW Edwards Lifesciences Corporation Common Stock | $50k to $100k | May 12, 2025 | 41 days after the trade |
| Bruce Westerman House · R-AR | Sale | EW Edwards Lifesciences Corporation Common Stock | $1,001 to $15k | Apr 21, 2025 | 21 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | EW Edwards Lifesciences Corporation Common Stock | $1,001 to $15k | Apr 8, 2025 | 30 days after the trade |
| Jefferson Shreve House · R-IN | Purchase | EW Edwards Lifesciences Corporation Common Stock | $15k to $50k | Apr 7, 2025 | 31 days after the trade |
| Bruce Westerman House · R-AR | Purchase | EW Edwards Lifesciences Corporation Common Stock | $1,001 to $15k | Mar 3, 2025 | 44 days after the trade |
Transactions
The last 28 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Common Stock10b5-1 | +9,500 | $45.28 | $430k | 56,436 | Mar 13, 2025 |
| Mar 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -9,500 | $67.96 | $646k | 46,936 | Mar 13, 2025 |
| Mar 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -9,500 | $0.00 | $0 | 9,500 | Mar 13, 2025 |
| Feb 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Common Stock10b5-1 | +6,500 | $45.28 | $294k | 53,436 | Feb 13, 2025 |
| Feb 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -100 | $76.26 | $7,626 | 53,336 | Feb 13, 2025 |
| Feb 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -6,400 | $75.74 | $485k | 46,936 | Feb 13, 2025 |
| Feb 13, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -6,500 | $0.00 | $0 | 19,000 | Feb 13, 2025 |
| Jan 16, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Common Stock10b5-1 | +5,000 | $45.28 | $226k | 51,936 | Jan 16, 2025 |
| Jan 16, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -5,000 | $68.75 | $344k | 46,936 | Jan 16, 2025 |
| Jan 16, 2025 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -5,000 | $0.00 | $0 | 25,500 | Jan 16, 2025 |
| Dec 16, 2024 | Lippis Daniel J. CVP, JAPAC | MOption exercise Common Stock10b5-1 | +2,500 | $45.28 | $113k | 25,689 | Dec 16, 2024 |
| Dec 16, 2024 | Lippis Daniel J. CVP, JAPAC | SOpen-market sale Common Stock10b5-1 | -2,500 | $74.08 | $185k | 23,189 | Dec 16, 2024 |
| Dec 16, 2024 | Lippis Daniel J. CVP, JAPAC | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -2,500 | $0.00 | $0 | 2,030 | Dec 16, 2024 |
| Dec 9, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Common Stock10b5-1 | +5,000 | $45.28 | $226k | 51,936 | Dec 9, 2024 |
| Dec 9, 2024 | Ullem Scott B. CVP, Chief Financial Officer | MOption exercise Common Stock10b5-1 | +11,250 | $45.28 | $509k | 41,811 | Dec 9, 2024 |
| Dec 9, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -5,000 | $71.75 | $359k | 46,936 | Dec 9, 2024 |
| Dec 9, 2024 | Ullem Scott B. CVP, Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -11,250 | $71.68 | $806k | 30,561 | Dec 9, 2024 |
| Dec 9, 2024 | Ullem Scott B. CVP, Chief Financial Officer | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -11,250 | $0.00 | $0 | 45,000 | Dec 9, 2024 |
| Dec 9, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -5,000 | $0.00 | $0 | 30,500 | Dec 9, 2024 |
| Dec 6, 2024 | Chopra Daveen CVP, TMTT | SOpen-market sale Common Stock | -1,750 | $73.27 | $128k | 27,583 | Dec 6, 2024 |
| Dec 6, 2024 | Markowitz Wayne GM & SVP, Surgical | SOpen-market sale Common Stock | -583 | $73.27 | $43k | 9,494 | Dec 6, 2024 |
| Nov 13, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Common Stock10b5-1 | +5,000 | $45.28 | $226k | 51,936 | Nov 13, 2024 |
| Nov 13, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -5,000 | $65.57 | $328k | 46,936 | Nov 13, 2024 |
| Nov 13, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -5,000 | $0.00 | $0 | 35,500 | Nov 13, 2024 |
| Nov 5, 2024 | Wood Larry L Global President TAVR & Surg | SOpen-market sale Common Stock10b5-1 | -25,000 | $65.91 | $1.6M | 198,526 | Nov 5, 2024 |
| Oct 15, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Common Stock10b5-1 | +5,000 | $45.28 | $226k | 51,936 | Oct 15, 2024 |
| Oct 15, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | SOpen-market sale Common Stock10b5-1 | -5,000 | $69.51 | $348k | 46,936 | Oct 15, 2024 |
| Oct 15, 2024 | BOBO DONALD E JR CVP,Strategy/Corp Development | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -5,000 | $0.00 | $0 | 40,500 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- BOBO DONALD E JRCVP,Strategy/Corp Development
- Chopra DaveenCVP, TMTT
- Lippis Daniel J.CVP, JAPAC
- Markowitz WayneGM & SVP, Surgical
- Ullem Scott B.CVP, Chief Financial Officer
- Wood Larry LGlobal President TAVR & Surg
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.